George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpact Health Regulatory News (IHR)

Share Price Information for Impact Health (IHR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 84.20
Bid: 84.00
Ask: 84.70
Change: -0.10 (-0.12%)
Spread: 0.70 (0.833%)
Open: 84.50
High: 85.00
Low: 84.00
Prev. Close: 84.30
IHR Live PriceLast checked at -
Impact Healthcare REIT is an Investment Trust

To seek to provide Shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth through exposure to a diversified portfolio of Healthcare Real Estate Assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 May 2023 16:49

RNS Number : 7789Z
Impact Healthcare REIT PLC
17 May 2023
 

17 May 2023

Impact Healthcare REIT plc

("Impact" or the "Company")

Result of 2023 Annual General Meeting

The Board of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, announces that at the Company's 2023 Annual General Meeting held today, all resolutions proposed at the AGM were voted on and passed by a poll by the Company's shareholders and the results of the poll, including the proxy votes received, are set out below.

 

Resolutions 1 to 12 (inclusive) were proposed as ordinary resolutions and resolutions 13 to 16 (inclusive) were proposed as special resolutions.

 

Resolution

Votes For*

%

Votes Against

%

Total votes validly cast

Total votes cast as % of issued share capital

Votes Withheld **

1

Receive the Annual Report and Financial Statements Year 31 December 2022

281,210,111

100.00%

0

0.00%

281,210,111

67.86%

226,521

2

Approve the directors' remuneration report

281,154,070

99.96%

115,981

0.04%

281,270,051

67.88%

166,581

3

Approve the Company's Dividend Policy

281,387,092

100.00%

0

0.00%

281,387,092

67.91%

49,540

4

Re-elect Rosemary Boot as a director

278,046,424

98.81%

3,343,574

1.19%

281,389,998

67.91%

46,634

5

Re-elect Philip Hall as a director

278,055,966

98.81%

3,334,922

1.19%

281,390,888

67.91%

45,744

6

Re-elect Amanda Aldridge as a director

279,416,802

99.30%

1,974,086

0.70%

281,390,888

67.91%

45,744

7

Re-elect Chris Santer as a director

279,425,480

99.30%

1,965,408

0.70%

281,390,888

67.91%

45,744

8

Elect Simon Laffin as a director

281,388,218

100.00%

2,670

0.00%

281,390,888

67.91%

45,744

9

To re-appoint BDO LLP as the Company's auditor

276,383,577

100.00%

5,434

0.00%

276,389,011

66.70%

5,047,621

10

To authorise the board of directors to determine the auditors remuneration

281,388,454

100.00%

2,434

0.00%

281,390,888

67.91%

45,744

11

To authorise the Directors to allot shares under section 551 Companies Act 2006

281,279,879

99.96%

104,277

0.04%

281,384,156

67.91%

48,680

12

Subject to the passing of resolution 11, to authorise the Directors to allot additional shares under section 551 Companies Act 2006

281,251,968

99.95%

138,920

0.05%

281,390,888

67.91%

45,744

13

Subject to the passing of resolution 11, to disapply statutory pre-emption rights under section 570 Companies Act 2006

280,589,017

99.72%

798,935

0.28%

281,387,952

67.91%

48,680

14

Subject to the passing of resolution 12, to disapply statutory pre-emption rights under section 570 Companies Act 2006

274,009,998

97.38%

7,377,954

2.62%

281,387,952

67.91%

48,680

15

To authorise the Company to make market purchase of its own ordinary shares

273,102,300

97.07%

8,240,537

2.93%

281,342,837

67.90%

93,795

16

To permit general meetings to be called on 14 days' notice

274,651,335

97.60%

6,739,553

2.40%

281,390,888

67.91%

45,744

 

Every shareholder has one vote for every Ordinary Share held. As at close of business on 17 May 2023, the share capital of the Company consisted of 414,368,169 Ordinary Shares with voting rights. The Company does not hold any shares in Treasury.

 

In accordance with Listing Rule 9.6.2, copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

* Includes discretionary votes.

** A vote withheld is not a vote in law and is not counted in the calculation of the votes for or against a resolution.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

via Maitland/AMO

JTC (UK) Limited - Company Secretary

Susan Fadil

0207 409 0181

Impact.CoSec@jtcgroup.com

 

Maitland/AMO (Communications Adviser)

James Benjamin

07747 113 930

impacthealth-maitland@maitland.co.uk

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

NOTES

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.

 

The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.

 

The Company has a progressive dividend policy with a target to grow its annual aggregate dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group's leases in the prior financial year.

 

On this basis, the target total dividend for the year ending 31 December 2023 is 6.77 pence per share(3), a 3.53% increase over the 6.54 pence in dividends paid or declared per ordinary share for the year ended 31 December 2022.

 

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.

 

(3) This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGARMATMTIBBRJ
Date   Source Headline
25th Apr 20247:00 amRNSDividend Declaration
17th Apr 20242:40 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
18th Mar 20247:00 amRNSBOARD CHANGES
11th Mar 20247:00 amRNSNotice of Full Year Results
14th Feb 20245:29 pmRNSHolding(s) in Company
8th Feb 202410:32 amRNSDirector Declaration
1st Feb 20249:33 amRNSDirector/PDMR Shareholding
31st Jan 20249:16 amEQSEdison issues update on Impact Healthcare REIT (IHR): Strong cash flow underpins further DPS growth
30th Jan 20247:00 amRNSUPDATE, DIVIDEND DECLARATION AND DIVIDEND TARGET
15th Jan 20245:29 pmRNSHolding(s) in Company
27th Dec 20234:07 pmRNSHolding(s) in Company
27th Dec 20231:42 pmRNSHolding(s) in Company
6th Dec 20235:42 pmRNSHolding(s) in Company
26th Oct 20231:20 pmEQSEdison issues update on Impact Healthcare REIT (IHR): On track to meet dividend target
20th Oct 20237:00 amRNSDividend Declaration and Third Quarter Update
23rd Aug 202311:17 amRNSEdison issues update on Impact Healthcare REIT
18th Aug 20237:00 amRNSINTEREST RATE CAP AND HEDGING UPDATE
3rd Aug 20237:00 amRNSNOTICE OF HALF YEAR RESULTS
29th Jun 20237:00 amRNS£24 Million Extension of Revolving Credit Facility
2nd Jun 20234:25 pmRNSTransfer of Operations & Related Party Transaction
26th May 20231:42 pmRNSHolding(s) in Company
17th May 20234:49 pmRNSResult of AGM
25th Apr 20237:00 amRNSDividend Declaration & Q1 Update to 31 March 2023
31st Mar 20235:10 pmRNSNotice of AGM
29th Mar 20239:36 amRNSDirector/PDMR Shareholding
29th Mar 20237:30 amRNSDirector Declaration
28th Mar 20237:00 amRNSAnnual Results for the year ended 31 December 2022
27th Mar 20235:06 pmRNSHolding(s) in Company
23rd Mar 202311:18 amRNSHolding(s) in Company
21st Mar 20237:00 amRNSNotice of Full Year Results
15th Feb 20237:00 amRNSDisposal of Care Home & Related Party Transaction
7th Feb 20233:49 pmRNSHolding(s) in Company
31st Jan 20237:00 amRNSQ4 2022 NAV, Dividend Declaration and Update
31st Jan 20237:00 amRNSTotal Voting Rights
10th Jan 20237:00 amRNSINVESTMENT IN PORTFOLIO OF SIX CARE HOMES
28th Dec 20227:00 amRNSREVOLVING CREDIT FACILITY
7th Dec 20227:00 amRNSBoard Changes
5th Dec 20224:51 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNS£25 MILLION EXTENSION OF REVOLVING CREDIT FACILITY
21st Oct 20227:00 amRNSNAV, Portfolio & Finance Update and Dividend
10th Oct 20227:00 amRNSDisposal of Care Home & Related Party Transaction
22nd Aug 20227:00 amRNSAcquisition of Two Care Homes and New Tenant
16th Aug 20227:00 amRNSHalf Year Results and Dividend
5th Aug 20229:00 amRNSNotice of Results
29th Jul 20224:46 pmRNSTotal Voting Rights
12th Jul 20223:41 pmRNSHolding(s) in Company
12th Jul 202211:03 amRNSHolding(s) in Company
8th Jul 20226:06 pmRNSHolding(s) in Company
6th Jul 20227:32 amRNSResults of the Placing and Offer for Subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.